News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Angelini Pharma and Quiver Bioscience Form Strategic Collaboration to Develop Therapies for Genetic Epilepsies
Tuesday, February 24, 2026Angelini Pharma part of the privately owned Angelini Industries and Quiver Bioscience a company focused on discovering therapies for central nervous system CNS disorders have entered a collaboration and licensing
Vanda Pharmaceuticals Receives FDA Approval for BYSANTI™ (milsaperidone) for Bipolar I Disorder and Schizophrenia
Tuesday, February 24, 2026Vanda Pharmaceuticals Inc Nasdaq VNDA has received approval from the US Food and Drug Administration FDA for BYSANTI milsaperidone tablets The medication is approved for the acute treatment
Sandoz Ranluspec Biosimilar to Lucentis Approved by European Commission
Tuesday, February 24, 2026The European Commission has approved Ranluspec Sandoz and Lupins biosimilar to Genentechs Lucentis ranibizumab marking a key advancement for ophthalmic treatments in Europe
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
Friday, February 20, 2026Roche has announced that the US Food and Drug Administration has accepted its New Drug Application NDA for giredestrant The investigational oral therapy is being reviewed in combination with everolimus
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security
Friday, February 20, 2026The European Parliament has adopted its position on the Critical Medicines Act paving the way for negotiations to strengthen Europes medicine supply chain resilience
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
Thursday, February 19, 2026Merck Co known as MSD outside the United States and Canada has entered into a research and development agreement with Mayo Clinic to advance AIenabled drug discovery and precision medicine
Johnson & Johnson Expands U.S. Footprint with More Than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Thursday, February 19, 2026Johnson Johnson has announced an investment of more than billion to build a nextgeneration cell therapy manufacturing plant in Montgomery County Pennsylvania The new site will expand the companys manufacturing capacity
Evinova Announces Strategic Collaborations with Astellas Pharma
Thursday, February 19, 2026Evinova has announced strategic collaborations with Astellas Pharma to advance global life sciences initiatives in Europe
Harmony Biosciences Secures U.S. FDA Approval for WAKIX® (pitolisant) to Treat Cataplexy in Paediatric Narcolepsy
Wednesday, February 18, 2026Harmony Biosciences has received approval from the US Food and Drug Administration for its supplemental new drug application sNDA for WAKIX pitolisant tablets to treat cataplexy in paediatric patients aged six years and older with narcolepsy
Deciphera Pharmaceuticals Announces U.S. FDA Acceptance of NDA for Tirabrutinib in Relapsed or Refractory PCNSL
Wednesday, February 18, 2026Deciphera Pharmaceuticals a member of Ono Pharmaceutical Co Ltd has announced that the US Food and Drug Administration has accepted for filing its New Drug Application NDA for tirabrutinib under the accelerated approval pathway
